A Randomized Phase 3 Study Comparing Pemetrexed-Carboplatin With Docetaxel-Carboplatin as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2007-2010

ABSTRACT

The purpose of this study is to compare the combination of pemetrexed and carboplatin with the combination of docetaxel and carboplatin in terms of survival without Grade 3 or 4 toxicity in previously untreated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).

URL

https://clinicaltrials.gov/show/NCT00520676

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The purpose of this study is to compare the combination of pemetrexed and carboplatin with the combination of docetaxel and carboplatin in terms of survival without Grade 3 or 4 toxicity in previously untreated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).", 
    "endDate": "2010-07-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00520676", 
    "keywords": [
      "carboplatin", 
      "first-line treatment", 
      "patient", 
      "non small cell lung cancer", 
      "docetaxel", 
      "survival", 
      "grade 3", 
      "toxicity", 
      "untreated patient", 
      "Non-Small-Cell Lung Carcinoma"
    ], 
    "name": "A Randomized Phase 3 Study Comparing Pemetrexed-Carboplatin With Docetaxel-Carboplatin as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00520676"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00004.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.417540.3", 
        "type": "Organization"
      }
    ], 
    "startDate": "2007-10-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1007/s40268-013-0032-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049938348", 
          "https://doi.org/10.1007/s40268-013-0032-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00520676"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00520676'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00520676'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00520676'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00520676'


 

This table displays all metadata directly associated to this object as RDF triples.

33 TRIPLES      16 PREDICATES      26 URIs      19 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00520676 schema:about anzsrc-for:3142
2 schema:description The purpose of this study is to compare the combination of pemetrexed and carboplatin with the combination of docetaxel and carboplatin in terms of survival without Grade 3 or 4 toxicity in previously untreated patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
3 schema:endDate 2010-07-01T00:00:00Z
4 schema:keywords Non-Small-Cell Lung Carcinoma
5 carboplatin
6 docetaxel
7 first-line treatment
8 grade 3
9 non small cell lung cancer
10 patient
11 survival
12 toxicity
13 untreated patient
14 schema:name A Randomized Phase 3 Study Comparing Pemetrexed-Carboplatin With Docetaxel-Carboplatin as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
15 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00520676
16 schema:sdDatePublished 2019-03-07T15:22
17 schema:sdLicense https://scigraph.springernature.com/explorer/license/
18 schema:sdPublisher N02f0e5abb5444f12a637a0788a77e07d
19 schema:sponsor https://www.grid.ac/institutes/grid.417540.3
20 schema:startDate 2007-10-01T00:00:00Z
21 schema:subjectOf sg:pub.10.1007/s40268-013-0032-6
22 schema:url https://clinicaltrials.gov/show/NCT00520676
23 sgo:license sg:explorer/license/
24 sgo:sdDataset clinical_trials
25 rdf:type schema:MedicalStudy
26 N02f0e5abb5444f12a637a0788a77e07d schema:name Springer Nature - SN SciGraph project
27 rdf:type schema:Organization
28 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
29 rdf:type schema:DefinedTerm
30 sg:pub.10.1007/s40268-013-0032-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049938348
31 https://doi.org/10.1007/s40268-013-0032-6
32 rdf:type schema:CreativeWork
33 https://www.grid.ac/institutes/grid.417540.3 schema:Organization
 




Preview window. Press ESC to close (or click here)


...